Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing

IMPORTANCE: Genetic testing can guide management of both cardiomyopathies and arrhythmias, but cost, yield, and uncertain results can be barriers to its use. It is unknown whether combined disease testing can improve diagnostic yield and clinical utility for patients with a suspected genetic cardiom...

Descripción completa

Detalles Bibliográficos
Autores principales: Dellefave-Castillo, Lisa M., Cirino, Allison L., Callis, Thomas E., Esplin, Edward D., Garcia, John, Hatchell, Kathryn E., Johnson, Britt, Morales, Ana, Regalado, Ellen, Rojahn, Susan, Vatta, Matteo, Nussbaum, Robert L., McNally, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366660/
https://www.ncbi.nlm.nih.gov/pubmed/35947370
http://dx.doi.org/10.1001/jamacardio.2022.2455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366660/
https://www.ncbi.nlm.nih.gov/pubmed/35947370
http://dx.doi.org/10.1001/jamacardio.2022.2455

Ejemplares similares